328 British Journal of General Practice, July 2017
for MNE is individualised based on diary data Box 1. Diagnostic questions to identify LUTS, suggestive of an from Step 2 of the diagnostic procedure, if underlying bladder dysfunction (including overactive bladder and performed, or on the general suitability for dysfunctional voiding)a the family if not. Leakage of urine during the day: Yes No Depending on aetiology, different treatment • Drops of urine in the underpants options are available. Nocturnal polyuria can — before voiding be treated using the vasopressin analogue — after voiding desmopressin, which reduces the amount • Very wet underpants of urine during the night. In most countries • Frequency of leakage (episodes/day) the recommended starting dose for children • Intermittent or continuous leakage every day is 120 µg/day (melt) or 200 mg/day (tablet). • History of daytime incontinence over 3.5 years of age Desmopressin treatment can be optimised Urinary frequency (≥8 voids/day) Yes No by following appropriate recommendations.5 Infrequent voiding (<3 voids/day) Yes No If children with nocturnal polyuria are Sudden and urgent need to urinate Yes No unresponsive to desmopressin despite good Holding manoeuvres (for example, leg crossing, pressing heel into perineum) Yes No adherence, referral is advised. Increasing the Needs to push in order to urinate (strained abdominal muscles to pass urine) Yes No dose is not recommended in primary care. Interrupted urinary stream, or several voids one after the other Yes No Small MVV and arousal problems in History of urinary tract infectionb Yes No children with MNE are treated using a Illness and/or malformation:b Yes No bedwetting alarm. Although this can be • of kidneys and/or urinary tract effective, the alarm should only be used in • of spinal cord motivated, supportive families because of the Constipationb Yes No likely burden caused by repeated triggering a Based on the clinical management tool of the ICCS.1 bAlthough history of urinary tract infections, constipation, and of a nocturnal alarm. Adherence should be illness/malformation of kidneys and/or urinary tract are not LUTS, they coincide with a higher frequency of LUTS. ICCS monitored. Enuresis caused by nocturnal = International Children’s Continence Society. LUTS = lower urinary tract symptoms. polyuria and small MVV can benefit from combination treatment with alarm and desmopressin. in resolution of the constipation and OAB but Although only evidence based for the REFERENCES not enuresis, Step 2 in the assessment (or improvement of NMNE, basic urotherapy 1. Vande Walle J, Rittig S, Bauer S, et al. Practical advice regarding drinking schedule and toilet consensus guidelines for the management of treatment) can be initiated. enuresis. Eur J Pediatr 2012; 171(6): 971–983. posture is often recommended in MNE. Step 2: Extended assessment Patients should drink sufficiently during 2. Neveus T, Eggert P, Evans J, et al. Evaluation of and treatment for monosymptomatic (recommended) the day (~1000 mL/day for child of 10 kg; enuresis: a standardization document from the 1500 mL/day for child of 20 kg), and achieve This second step is not essential but is International Children’s Continence Society. J urinary output ~30–40 mL/kg, with fluid Urol 2010; 183(2): 441–447. advisable because the chance of identifying the restriction before sleep. A trial of this advice 3. Austin PF, Bauer SB, Bower W, et al. The true pathophysiology of enuresis, and thereby can be recommended before the start of standardization of terminology of lower urinary prescribing effective first-line treatment, tract function in children and adolescents: alarm/desmopressin. increases. In this extended assessment update report from the standardization Although both alarm and desmopressin procedure, the patient completes two diaries. committee of the International Children’s treatment are successful in a large Continence Society. Neurourol Urodyn 2016; Examples of the diaries can be found at http:// proportion of patients, some are therapy 35(4): 471–481. www.drydawn.ie. The first is a 2-day daytime resistant. This should be mentioned at the 4. Hjälmås K. Urodynamics in normal infants and bladder diary to assess the bladder capacity first consultation to minimise frustration and children. Scand J Urol Nephrol Suppl 1988; of the child by measuring the MVV during 114: 20–27. drop-outs. Enuresis is a complex condition, daytime (excluding morning void). Drinking and a more complex approach is sometimes 5. Kamperis K, Van Herzeele C, Rittig S, Vande Walle J. Optimizing response to desmopressin and voiding habits can also be recorded. necessary, for example, due to comorbidities in patients with monosymptomatic nocturnal The second diary records the amount of including sleep and psychological problems. enuresis. Pediatr Nephrol 2017; 32(2): 217–226. urine produced during 7 consecutive nights Specialist referral is then necessary. to ascertain whether nocturnal polyuria is Whatever the choice of treatment, family present. Urine volume can be calculated by doctors should recognise that enuresis can Acknowledgements the sum of the diaper weight (1 g = 1 mL), be a heavy burden for families and offer basic Editorial assistance with this manuscript was the morning void volume, and any nocturia advice on how to tackle the condition. provided by Caroline Loat, PhD, Articuloat. void volumes. Funding Open access TREATMENT Funded by Ferring Pharmaceuticals. This article is Open Access: CC BY-NC First-line treatment for monosymptomatic 4.0 licence (http://creativecommons.org/ Provenance nocturnal enuresis licenses/by-nc/4.0/). Freely submitted; externally peer reviewed. As mentioned, treatment of enuresis Discuss this article in primary care is only advisable if MNE Competing interests Contribute and read comments about this is suspected (that is, no daytime bladder The authors have declared no competing article: bjgp.org/letters dysfunction is detected). Treatment selection interests.
British Journal of General Practice, July 2017 329
Lack of Association Between MTHFR A1298C Polymorphism and Outcome of Methotrexate Treatment in Rheumatoid Arthritis Patients: Evidence From A Systematic Review and Meta-Analysis